Getting to the Heart of the Matter: What Additional Proof Is Needed to Demonstrate the Value of Intensity-Modulated Radiotherapy in Thoracic Oncology?
- PMID: 28481710
- DOI: 10.1200/JCO.2017.73.1786
Getting to the Heart of the Matter: What Additional Proof Is Needed to Demonstrate the Value of Intensity-Modulated Radiotherapy in Thoracic Oncology?
Comment in
-
Reply to J.P. Gross et al.J Clin Oncol. 2017 Jul 1;35(19):2216-2217. doi: 10.1200/JCO.2017.73.2230. Epub 2017 May 8. J Clin Oncol. 2017. PMID: 28481702 No abstract available.
Comment on
-
Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.J Clin Oncol. 2017 May 1;35(13):1387-1394. doi: 10.1200/JCO.2016.70.0229. Epub 2017 Jan 23. J Clin Oncol. 2017. PMID: 28113017 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
